FDA’s import alert on Dabur facilities may be due to unauthorized export
Responding to the U. S. Food & Drug Administration's (FDA's) imposition of an import alert on Dabur's two Himachal Pradesh-based manufacturing facilities, the Indian FMCG giant claimed that the products in question were exported without its consent and knowledge.
The FDA imposed the alert after two unapproved products from Dabar's Baddi and Nalagarh facilities were found selling in the U. S. market.
The two products in question are: Meswak toothpaste and fairness cream bleach, which are manufactured at the company's Baddi and Nalagarh facilities respectively.
Dabur said in a statement, the products "seem to be part of an unauthorized export by an independent trader, without any consent or knowledge of the company."
The FMCG giant also said that it had already taken up the issue with the U. S. food & drugs regulator.
A spokesperson for the company added that Indian companies regularly get such import alerts from several developed countries, including the U. S. But such matters are resolved after the companies prepare a dossier and submit required information to the concerned authorities within the fixed time.
The spokesperson further added that the U. S. market's contribution to Dabur India's consolidates sales and revenue is insignificant.